01 1Zhejiang Huahai Pharmaceutical
01 1SACUBITRIL VALSARTAN SODIUM
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-08-27
Pay. Date : 2024-08-16
DMF Number : 40137
Submission : 2024-07-12
Status : Active
Type : II
20
Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SACUBITRIL VALSARTAN SODIUM, with a corresponding US DMF Number 40137.
Remarkably, this DMF maintains an Active status since its submission on July 12, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 27, 2024, and payment made on August 16, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
